2 news items
Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
CHRS
9 May 24
-based compensation of $1.0 million was classified within Restructuring charges related to reduction in workforce.
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
CHRS
13 Mar 24
was classified
- Prev
- 1
- Next